+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Bioinformatics Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Bioinformatics Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
From
From
Biobanking Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Biobanking Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 140 Pages
  • Global
From
Biotechnology Services Market Report 2025 - Product Thumbnail Image

Biotechnology Services Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Biotech Ingredient Market Report 2025 - Product Thumbnail Image

Biotech Ingredient Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Dermatology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Dermatology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
From
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 194 Pages
  • Global
From
From
From
Loading Indicator